Insider: Touchon Pascal President and CEO - Atara Biotherapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 70,403 | 0 | 70,403 |
| Value | $947,624.38 | $0.00 | $947,624.38 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/16/2024 | DDS | 2,762 | Direct | COM | $6.63 | $18,309.30 | 70,403 |
| 08/16/2024 | DDS | 276 | Direct | COM | $6.63 | $1,829.88 | 70,127 |
| 05/16/2024 | DDS | 81,506 | Direct | COM | $0.62 | $50,289.20 | 1,829,146 |
| 03/04/2024 | DDS | 24,844 | Direct | COM | $0.72 | $17,887.68 | 1,910,652 |
| 11/16/2023 | DDS | 20,409 | Direct | COM | $0.39 | $7,939.10 | 655,496 |
| 08/16/2023 | DDS | 21,432 | Direct | COM | $1.65 | $35,405.66 | 685,239 |
| 08/16/2023 | DDS | 9,334 | Direct | COM | $1.65 | $15,429.10 | 675,905 |
| 06/27/2023 | DDS | 14,291 | Direct | COM | $1.66 | $23,723.06 | 706,671 |
| 05/16/2023 | DDS | 29,766 | Direct | COM | $2.04 | $60,633.34 | 720,962 |
| 03/02/2023 | DDS | 15,679 | Direct | COM | $3.63 | $56,867.73 | 750,728 |
| 11/16/2022 | DDS | 15,591 | Direct | COM | $4.49 | $70,003.59 | 441,696 |
| 08/16/2022 | DDS | 14,806 | Direct | COM | $5.04 | $74,548.21 | 457,287 |
| 06/27/2022 | DDS | 14,220 | Direct | COM | $7.20 | $102,384.00 | 472,093 |
| 05/17/2022 | DDS | 13,913 | Direct | COM | $5.32 | $73,961.51 | 486,313 |
| 03/01/2022 | DDS | 8,828 | Direct | COM | $9.86 | $87,008.77 | 500,226 |
| 11/16/2021 | DDS | 8,402 | Direct | COM | $17.12 | $143,816.19 | 328,489 |
| 08/17/2021 | DDS | 8,223 | Direct | COM | $12.53 | $103,050.64 | 336,891 |
| 06/25/2021 | DDS | 14,194 | Direct | COM | $16.32 | $231,660.27 | 345,114 |
| 05/18/2021 | DDS | 8,313 | Direct | COM | $14.55 | $120,954.15 | 359,308 |
| 03/02/2021 | DDS | 4,887 | Direct | COM | $16.74 | $81,808.38 | 367,621 |
| 08/18/2020 | DDS | 4,807 | Direct | COM | $12.09 | $58,116.63 | 260,037 |
| 06/25/2020 | DDS | 12,135 | Direct | COM | $12.92 | $156,784.20 | 264,844 |
| 06/25/2020 | DDS | 12,135 | Direct | COM | $12.92 | $156,784.20 | 264,844 |
| 05/18/2020 | DDS | 3,195 | Direct | COM | $11.22 | $35,847.90 | 276,979 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research